By CHRISTOPHER CARBONE, U.S. SCIENCE AND TECHNOLOGY EDITOR FOR DAILYMAIL.COM Scientists have figured out a way to create eye tissue using stem cells and 3D printing – in new research that could lead to breakthroughs in treating a range of degenerative eye diseases. A team of researchers from the National Eye Institute (NEI), part of the National Institutes of...
ELSEVIER IMAGE: : RUNX1 INHIBITION COMBINED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (ANTI-VEGF) THERAPY ACHIEVES BETTER CONTROL OF EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION ACTIVITY COMPARED TO MONOTHERAPY. CREDIT: THE AMERICAN JOURNAL OF PATHOLOGY Philadelphia, February 22, 2021 – Runt-related transcription factor 1 (RUNX1) has been linked to retinal neovascularization and the development of abnormal blood vessels, which result...
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study published online by JAMA Ophthalmology. The advent of intravitreous (in the vitreous, the fluid behind the lens in the eye) anti-vascular endothelial growth factor (VEGF) injections to...
